Chronic Kidney Disease

Anemia Due to Chronic Kidney Disease
PROCRIT® is indicated for the treatment of anemia due to chronic kidney disease (CKD), including patients on dialysis and not on dialysis to decrease the need for red blood cell (RBC) transfusion.

  • PROCRIT® is contraindicated in patients with uncontrolled hypertension, pure red cell aplasia (PRCA) that begins after treatment with PROCRIT® or other erythropoietin protein drugs, or severe allergic reactions to PROCRIT®. PROCRIT® from multidose vials contains benzyl alcohol and is contraindicated in neonates, infants, pregnant women, and nursing mothers.
*Approximately 10,000-Units, 15,000-Units, or 20,000-Units SC or IV used per week based on sample starting doses of 50 Units/kg TIW, 75 Units/kg TIW, or 100 Units/kg TIW, respectively, for a 70-kg patient.